"";"ID";"Description";"GeneRatio";"BgRatio";"RichFactor";"FoldEnrichment";"zScore";"pvalue";"p.adjust";"qvalue";"geneID";"Count"
"GO:0002455";"GO:0002455";"humoral immune response mediated by circulating immunoglobulin";"8/19";"56/18888";0,142857142857143;142,015037593985;33,5347495078112;2,6105087158578e-16;3,08040028471221e-13;1,31624597357462e-13;"CD81/C3/C1QA/CFI/C4A/FCGR2B/CR2/C4B";8
"GO:0016064";"GO:0016064";"immunoglobulin mediated immune response";"10/19";"208/18888";0,0480769230769231;47,7935222672065;21,5334103609139;1,78859711199517e-15;6,39923512225034e-13;2,73437432966808e-13;"CD81/FCGR2A/C3/C1QA/CFI/C4A/FCGR2B/FCGR3B/CR2/C4B";10
"GO:0002443";"GO:0002443";"leukocyte mediated immunity";"12/19";"469/18888";0,0255863539445629;25,4355291213107;17,0043091989597;2,05765733357704e-15;6,39923512225034e-13;2,73437432966808e-13;"CD81/FCGR2A/C3/TLR4/C1QA/CFI/C4A/FCGR2B/FCGR3B/CR2/C4B/ITGAM";12
"GO:0019724";"GO:0019724";"B cell mediated immunity";"10/19";"212/18888";0,0471698113207547;46,8917576961271;21,3228149605557;2,16923224483062e-15;6,39923512225034e-13;2,73437432966808e-13;"CD81/FCGR2A/C3/C1QA/CFI/C4A/FCGR2B/FCGR3B/CR2/C4B";10
"GO:0002460";"GO:0002460";"adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains";"11/19";"385/18888";0,0285714285714286;28,403007518797;17,2381783064039;1,43031150525412e-14;3,37553515239971e-12;1,44235623371941e-12;"CD81/FCGR2A/C3/TLR4/C1QA/CFI/C4A/FCGR2B/FCGR3B/CR2/C4B";11
"GO:0006956";"GO:0006956";"complement activation";"7/19";"67/18888";0,104477611940299;103,861743912019;26,7641703507043;2,49327914994503e-13;4,90344899489189e-11;2,09522932074328e-11;"C3/CFH/C1QA/CFI/C4A/CR2/C4B";7
"GO:0002449";"GO:0002449";"lymphocyte mediated immunity";"10/19";"372/18888";0,0268817204301075;26,723259762309;15,9003884986736;6,14431967995161e-13;1,03575674604899e-10;4,42575808525838e-11;"CD81/FCGR2A/C3/C1QA/CFI/C4A/FCGR2B/FCGR3B/CR2/C4B";10
"GO:0006959";"GO:0006959";"humoral immune response";"9/19";"258/18888";0,0348837209302326;34,6780905752754;17,283621005174;1,18081235552536e-12;1,7416982243999e-10;7,44222524074535e-11;"CD81/C3/CFH/C1QA/CFI/C4A/FCGR2B/CR2/C4B";9
"GO:0006958";"GO:0006958";"complement activation, classical pathway";"6/19";"42/18888";0,142857142857143;142,015037593985;29,0311558830389;2,21115543376433e-12;2,89907045760213e-10;1,23876427224926e-10;"C3/C1QA/CFI/C4A/CR2/C4B";6
"GO:0001794";"GO:0001794";"type IIa hypersensitivity";"4/19";"10/18888";0,4;397,642105263158;39,8111453340669;1,52950858728174e-10;1,64074557544769e-08;7,0108575436168e-09;"FCGR2A/C3/FCGR2B/FCGR3B";4
"GO:0002445";"GO:0002445";"type II hypersensitivity";"4/19";"10/18888";0,4;397,642105263158;39,8111453340669;1,52950858728174e-10;1,64074557544769e-08;7,0108575436168e-09;"FCGR2A/C3/FCGR2B/FCGR3B";4
"GO:0002697";"GO:0002697";"regulation of immune effector process";"8/19";"385/18888";0,0207792207792208;20,6567327409433;12,3652947099794;1,72183184543441e-09;1,6931346480105e-07;7,23471450844809e-08;"CD81/C3/TLR4/CFH/FCGR2B/TLR7/CR2/ITGAM";8
"GO:0006909";"GO:0006909";"phagocytosis";"7/19";"237/18888";0,029535864978903;29,3617588274484;13,9424828854322;1,98655061955699e-09;1,80317671621327e-07;7,70492102645992e-08;"FCGR2A/C3/TLR4/C4A/FCGR2B/C4B/ITGAM";7
"GO:0002524";"GO:0002524";"hypersensitivity";"4/19";"18/18888";0,222222222222222;220,912280701754;29,6199031049119;2,2174057575429e-09;1,86895628135759e-07;7,98599517190263e-08;"FCGR2A/C3/FCGR2B/FCGR3B";4
"GO:0045807";"GO:0045807";"positive regulation of endocytosis";"6/19";"155/18888";0,0387096774193548;38,481494057725;14,8683551071902;6,88448911022147e-09;5,41579810004089e-07;2,31415458512006e-07;"APOE/FCGR2A/C3/C4A/FCGR2B/C4B";6
"GO:0050766";"GO:0050766";"positive regulation of phagocytosis";"5/19";"72/18888";0,0694444444444444;69,0350877192982;18,3535210176423;7,79564892200394e-09;5,7492910799779e-07;2,45665515371045e-07;"FCGR2A/C3/C4A/FCGR2B/C4B";5
"GO:0002757";"GO:0002757";"immune response-activating signaling pathway";"8/19";"500/18888";0,016;15,9056842105263;10,7189814445444;1,33374715561534e-08;9,25777437427121e-07;3,95581973708823e-07;"CD81/C3/IRAK1/TLR4/FCGR2B/TLR7/CR2/ITGAM";8
"GO:0002437";"GO:0002437";"inflammatory response to antigenic stimulus";"5/19";"84/18888";0,0595238095238095;59,1729323308271;16,9558406351072;1,70735674776352e-08;1,11926720131164e-06;4,78259580221478e-07;"CD81/FCGR2A/C3/FCGR2B/FCGR3B";5
"GO:0002438";"GO:0002438";"acute inflammatory response to antigenic stimulus";"4/19";"30/18888";0,133333333333333;132,547368421053;22,8812014427072;1,97078681654375e-08;1,2069015642788e-06;5,15705485539292e-07;"FCGR2A/C3/FCGR2B/FCGR3B";4
"GO:0002429";"GO:0002429";"immune response-activating cell surface receptor signaling pathway";"7/19";"332/18888";0,0210843373493976;20,9600507292327;11,6431997714887;2,04559587165899e-08;1,2069015642788e-06;5,15705485539292e-07;"CD81/C3/IRAK1/TLR4/FCGR2B/CR2/ITGAM";7
"GO:0002768";"GO:0002768";"immune response-regulating cell surface receptor signaling pathway";"7/19";"360/18888";0,0194444444444444;19,3298245614035;11,1424100294118;3,56682697098088e-08;2,00421705988449e-06;8,56396049674105e-07;"CD81/C3/IRAK1/TLR4/FCGR2B/CR2/ITGAM";7
"GO:0050764";"GO:0050764";"regulation of phagocytosis";"5/19";"100/18888";0,05;49,7052631578947;15,4959949740228;4,12265974391324e-08;2,21124477173528e-06;9,44858381499732e-07;"FCGR2A/C3/C4A/FCGR2B/C4B";5
"GO:0001906";"GO:0001906";"cell killing";"6/19";"226/18888";0,0265486725663717;26,3921751280857;12,1859356421167;6,54167770966888e-08;3,35616508583012e-06;1,43407946129583e-06;"FCGR2A/C3/CFH/FCGR2B/FCGR3B/ITGAM";6
"GO:0002444";"GO:0002444";"myeloid leukocyte mediated immunity";"5/19";"112/18888";0,0446428571428571;44,3796992481203;14,6109299351985;7,29167605545247e-08;3,58507406059746e-06;1,53189159235164e-06;"FCGR2A/C3/FCGR2B/FCGR3B/ITGAM";5
"GO:2000425";"GO:2000425";"regulation of apoptotic cell clearance";"3/19";"10/18888";0,3;298,231578947368;29,8332663888445;1,03094379541319e-07;4,86605471435024e-06;2,07925085474912e-06;"C3/C4A/C4B";3
"GO:0002703";"GO:0002703";"regulation of leukocyte mediated immunity";"6/19";"246/18888";0,024390243902439;24,2464698331194;11,6456078351064;1,08109131489578e-07;4,9064913522193e-06;2,09652931107319e-06;"CD81/C3/TLR4/FCGR2B/CR2/ITGAM";6
"GO:0002920";"GO:0002920";"regulation of humoral immune response";"4/19";"46/18888";0,0869565217391304;86,4439359267734;18,4111327826727;1,1616370627438e-07;5,07678420013958e-06;2,16929494368141e-06;"C3/CFH/FCGR2B/CR2";4
"GO:0006898";"GO:0006898";"receptor-mediated endocytosis";"6/19";"259/18888";0,0231660231660232;23,0294655557813;11,3277308156328;1,46567765722356e-07;6,176784412585e-06;2,63932179627851e-06;"CD81/APOE/C3/SCARB2/FCGR2B/ITGAM";6
"GO:0030100";"GO:0030100";"regulation of endocytosis";"6/19";"291/18888";0,0206185567010309;20,4970157352143;10,6359684291599;2,91153872650889e-07;1,18469506802775e-05;5,06216715062707e-06;"APOE/FCGR2A/C3/C4A/FCGR2B/C4B";6
"GO:0098883";"GO:0098883";"synapse pruning";"3/19";"14/18888";0,214285714285714;213,022556390977;25,1824486731404;3,11925536350707e-07;1,22690710964612e-05;5,24253796182417e-06;"C3/C1QA/ITGAM";3
"GO:0001819";"GO:0001819";"positive regulation of cytokine production";"7/19";"500/18888";0,014;13,9174736842105;9,28921871521077;3,34002526675302e-07;1,27136445637695e-05;5,43250289566959e-06;"CD81/FCGR2A/C3/IRAK1/TLR4/FCGR2B/TLR7";7
"GO:0002430";"GO:0002430";"complement receptor mediated signaling pathway";"3/19";"15/18888";0,2;198,821052631579;24,3210049676062;3,89659164101651e-07;1,43686816762484e-05;6,13969538173325e-06;"C3/CR2/ITGAM";3
"GO:0006957";"GO:0006957";"complement activation, alternative pathway";"3/19";"18/18888";0,166666666666667;165,684210526316;22,1812549218833;6,97486024279294e-07;2,49404093530172e-05;1,06569634969627e-05;"C3/CFH/CR2";3
"GO:0030449";"GO:0030449";"regulation of complement activation";"3/19";"22/18888";0,136363636363636;135,55980861244;20,0387503405001;1,31299138703144e-06;4,55685246087384e-05;1,9471296420683e-05;"C3/CFH/CR2";3
"GO:0150146";"GO:0150146";"cell junction disassembly";"3/19";"27/18888";0,111111111111111;110,456140350877;18,0602394013575;2,48591791851131e-06;8,38109469669528e-05;3,58121709162983e-05;"C3/C1QA/ITGAM";3
"GO:0050727";"GO:0050727";"regulation of inflammatory response";"6/19";"425/18888";0,0141176470588235;14,034427244582;8,62420618286169;2,65135808638729e-06;8,69056261649168e-05;3,71345182274711e-05;"CD81/APOE/C3/TLR4/FCGR2B/TLR7";6
"GO:0042100";"GO:0042100";"B cell proliferation";"4/19";"104/18888";0,0384615384615385;38,2348178137652;12,082469610517;3,15456670365718e-06;0,000100594695306407;4,29838171737457e-05;"CD81/TLR4/FCGR2B/CR2";4
"GO:0045088";"GO:0045088";"regulation of innate immune response";"6/19";"440/18888";0,0136363636363636;13,555980861244;8,45641302969022;3,23949018783345e-06;0,000100594695306407;4,29838171737457e-05;"APOE/IRAK1/TLR4/CFH/FCGR2B/TLR7";6
"GO:0002526";"GO:0002526";"acute inflammatory response";"4/19";"109/18888";0,036697247706422;36,4809270883631;11,7884261045118;3,8045626500998e-06;0,000115112408387635;4,91871932361081e-05;"FCGR2A/C3/FCGR2B/FCGR3B";4
"GO:0042116";"GO:0042116";"macrophage activation";"4/19";"110/18888";0,0363636363636364;36,1492822966507;11,7319981364223;3,94561761204818e-06;0,000116395719555421;4,97355483202915e-05;"TLR4/C1QA/FCGR2B/ITGAM";4
"GO:0002699";"GO:0002699";"positive regulation of immune effector process";"5/19";"257/18888";0,0194552529182879;19,340569322138;9,39388285156637;4,46272540862638e-06;0,000128439414199491;5,4881783587472e-05;"CD81/C3/TLR4/TLR7/ITGAM";5
"GO:0050808";"GO:0050808";"synapse organization";"6/19";"493/18888";0,0121703853955375;12,0986441763638;7,92368751559226;6,23227305952893e-06;0,000175097195482003;7,48185161783047e-05;"APOE/C3/C1QA/FCGR2B/MECP2/ITGAM";6
"GO:0055094";"GO:0055094";"response to lipoprotein particle";"3/19";"38/18888";0,0789473684210526;78,4819944598338;15,1712288943792;7,11968797124815e-06;0,000195377483862159;8,34842237020285e-05;"CD81/APOE/TLR4";3
"GO:0097242";"GO:0097242";"amyloid-beta clearance";"3/19";"39/18888";0,0769230769230769;76,4696356275304;14,9707737800206;7,70809431124826e-06;0,000206717074710749;8,83295974901415e-05;"APOE/C3/ITGAM";3
"GO:0071402";"GO:0071402";"cellular response to lipoprotein particle stimulus";"3/19";"41/18888";0,0731707317073171;72,7394094993581;14,5919206415963;8,97952684861272e-06;0,000235463148474734;0,000100612710186795;"CD81/APOE/TLR4";3
"GO:0001909";"GO:0001909";"leukocyte mediated cytotoxicity";"4/19";"144/18888";0,0277777777777778;27,6140350877193;10,1728978069688;1,14891583893919e-05;0,000294721889119184;0,000125933795618278;"FCGR2A/FCGR2B/FCGR3B/ITGAM";4
"GO:0002861";"GO:0002861";"regulation of inflammatory response to antigenic stimulus";"3/19";"48/18888";0,0625;62,1315789473684;13,4564230126875;1,45047283978048e-05;0,000351463836001588;0,000150179462484175;"CD81/C3/FCGR2B";3
"GO:0043277";"GO:0043277";"apoptotic cell clearance";"3/19";"48/18888";0,0625;62,1315789473684;13,4564230126875;1,45047283978048e-05;0,000351463836001588;0,000150179462484175;"C3/C4A/C4B";3
"GO:0050729";"GO:0050729";"positive regulation of inflammatory response";"4/19";"153/18888";0,0261437908496732;25,9896800825593;9,84834856809285;1,45946847153202e-05;0,000351463836001588;0,000150179462484175;"CD81/C3/TLR4/TLR7";4
"GO:0006911";"GO:0006911";"phagocytosis, engulfment";"3/19";"49/18888";0,0612244897959184;60,8635875402793;13,3142192785904;1,54408713169255e-05;0,00035725937556808;0,000152655879480027;"C3/FCGR2B/ITGAM";3
"GO:0042551";"GO:0042551";"neuron maturation";"3/19";"49/18888";0,0612244897959184;60,8635875402793;13,3142192785904;1,54408713169255e-05;0,00035725937556808;0,000152655879480027;"C3/C1QA/MECP2";3
"GO:0007254";"GO:0007254";"JNK cascade";"4/19";"171/18888";0,0233918128654971;23,2539242843952;9,27620610479432;2,26073631688512e-05;0,000513013241139316;0,000219209047730359;"IRAK1/TLR4/FCGR2B/TLR7";4
"GO:0002886";"GO:0002886";"regulation of myeloid leukocyte mediated immunity";"3/19";"57/18888";0,0526315789473684;52,3213296398892;12,3135274862818;2,43979782633949e-05;0,000543200270769924;0,000232107876626935;"C3/FCGR2B/ITGAM";3
"GO:0099024";"GO:0099024";"plasma membrane invagination";"3/19";"58/18888";0,0517241379310345;51,4192377495463;12,2030660179566;2,57124286650594e-05;0,000561864181940187;0,000240082910927163;"C3/FCGR2B/ITGAM";3
"GO:0002706";"GO:0002706";"regulation of lymphocyte mediated immunity";"4/19";"186/18888";0,021505376344086;21,3786078098472;8,86279707076501;3,1434689339909e-05;0,000650770675300186;0,000278072393816939;"CD81/C3/FCGR2B/CR2";4
"GO:0002712";"GO:0002712";"regulation of B cell mediated immunity";"3/19";"62/18888";0,0483870967741935;48,1018675721562;11,7879637882696;3,14355326204327e-05;0,000650770675300186;0,000278072393816939;"C3/FCGR2B/CR2";3
"GO:0002889";"GO:0002889";"regulation of immunoglobulin mediated immune response";"3/19";"62/18888";0,0483870967741935;48,1018675721562;11,7879637882696;3,14355326204327e-05;0,000650770675300186;0,000278072393816939;"C3/FCGR2B/CR2";3
"GO:0002700";"GO:0002700";"regulation of production of molecular mediator of immune response";"4/19";"187/18888";0,0213903743315508;21,2642837039122;8,83697229822389;3,21013107548114e-05;0,000653095632597887;0,000279065841226037;"CD81/TLR4/FCGR2B/TLR7";4
"GO:0030888";"GO:0030888";"regulation of B cell proliferation";"3/19";"64/18888";0,046875;46,5986842105263;11,5949849482821;3,4586624159574e-05;0,000691732483191481;0,000295575253745512;"CD81/TLR4/FCGR2B";3
"GO:0002822";"GO:0002822";"regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains";"4/19";"192/18888";0,0208333333333333;20,7105263157895;8,71080585048888;3,55913103555316e-05;0,000699962436992121;0,000299091888777187;"CD81/C3/FCGR2B/CR2";4
"GO:0010324";"GO:0010324";"membrane invagination";"3/19";"65/18888";0,0461538461538462;45,8817813765182;11,5018100626971;3,62371303970648e-05;0,00070098055522191;0,000299526927699639;"C3/FCGR2B/ITGAM";3
"GO:0002883";"GO:0002883";"regulation of hypersensitivity";"2/19";"10/18888";0,2;198,821052631579;19,855387443622;4,29342979341963e-05;0,000817136638102447;0,000349160079974194;"C3/FCGR2B";2
"GO:0002819";"GO:0002819";"regulation of adaptive immune response";"4/19";"207/18888";0,0193236714975845;19,209763539283;8,35936459096462;4,77376268534991e-05;0,000894133328367126;0,000382060539061421;"CD81/C3/FCGR2B/CR2";4
"GO:0032481";"GO:0032481";"positive regulation of type I interferon production";"3/19";"73/18888";0,0410958904109589;40,8536409516943;10,8258292017312;5,13363855063623e-05;0,000937631074915852;0,000400646998113018;"IRAK1/TLR4/TLR7";3
"GO:0002924";"GO:0002924";"negative regulation of humoral immune response mediated by circulating immunoglobulin";"2/19";"11/18888";0,181818181818182;180,746411483254;18,9223003558291;5,24437719868188e-05;0,000937631074915852;0,000400646998113018;"FCGR2B/CR2";2
"GO:0097278";"GO:0097278";"complement-dependent cytotoxicity";"2/19";"11/18888";0,181818181818182;180,746411483254;18,9223003558291;5,24437719868188e-05;0,000937631074915852;0,000400646998113018;"C3/CFH";2
"GO:0002224";"GO:0002224";"toll-like receptor signaling pathway";"3/19";"76/18888";0,0394736842105263;39,2409972299169;10,5999146550937;5,79148632513731e-05;0,00101999311397941;0,000435840054947489;"IRAK1/TLR4/TLR7";3
"GO:0002720";"GO:0002720";"positive regulation of cytokine production involved in immune response";"3/19";"81/18888";0,037037037037037;36,8187134502924;10,2512441767202;7,00656826275445e-05;0,00121584566912504;0,00051952727521043;"CD81/TLR4/TLR7";3
"GO:0002863";"GO:0002863";"positive regulation of inflammatory response to antigenic stimulus";"2/19";"13/18888";0,153846153846154;152,939271255061;17,3892993386521;7,42855973096937e-05;0,00123460570176674;0,000527543381932443;"CD81/C3";2
"GO:0032490";"GO:0032490";"detection of molecule of bacterial origin";"2/19";"13/18888";0,153846153846154;152,939271255061;17,3892993386521;7,42855973096937e-05;0,00123460570176674;0,000527543381932443;"TLR4/C4B";2
"GO:1902950";"GO:1902950";"regulation of dendritic spine maintenance";"2/19";"13/18888";0,153846153846154;152,939271255061;17,3892993386521;7,42855973096937e-05;0,00123460570176674;0,000527543381932443;"APOE/FCGR2B";2
"GO:0043410";"GO:0043410";"positive regulation of MAPK cascade";"5/19";"475/18888";0,0105263157894737;10,4642659279778;6,62911130875071;8,5534279779473e-05;0,00139309368751742;0,000595264831686748;"CD81/APOE/IRAK1/TLR4/FCGR2B";5
"GO:0002274";"GO:0002274";"myeloid leukocyte activation";"4/19";"241/18888";0,016597510373444;16,4996724175584;7,68440779390061;8,61829145667556e-05;0,00139309368751742;0,000595264831686748;"TLR4/C1QA/FCGR2B/ITGAM";4
"GO:0048708";"GO:0048708";"astrocyte differentiation";"3/19";"88/18888";0,0340909090909091;33,88995215311;9,8131740457748;8,97163027578626e-05;0,001430611314247;0,0006112960031439;"TLR4/C1QA/MECP2";3
"GO:0002713";"GO:0002713";"negative regulation of B cell mediated immunity";"2/19";"15/18888";0,133333333333333;132,547368421053;16,1730218209;9,98799092885043e-05;0,00153062718130435;0,00065403248871078;"FCGR2B/CR2";2
"GO:0002890";"GO:0002890";"negative regulation of immunoglobulin mediated immune response";"2/19";"15/18888";0,133333333333333;132,547368421053;16,1730218209;9,98799092885043e-05;0,00153062718130435;0,00065403248871078;"FCGR2B/CR2";2
"GO:0016322";"GO:0016322";"neuron remodeling";"2/19";"15/18888";0,133333333333333;132,547368421053;16,1730218209;9,98799092885043e-05;0,00153062718130435;0,00065403248871078;"C3/C1QA";2
"GO:0002864";"GO:0002864";"regulation of acute inflammatory response to antigenic stimulus";"2/19";"16/18888";0,125;124,263157894737;15,6519396813226;0,000114079999790777;0,00170397974371034;0,000728105528311556;"C3/FCGR2B";2
"GO:0007252";"GO:0007252";"I-kappaB phosphorylation";"2/19";"16/18888";0,125;124,263157894737;15,6519396813226;0,000114079999790777;0,00170397974371034;0,000728105528311556;"TLR4/TLR7";2
"GO:0002921";"GO:0002921";"negative regulation of humoral immune response";"2/19";"17/18888";0,117647058823529;116,953560371517;15,1773147263802;0,000129213118706722;0,00190589350092414;0,000814382682375259;"FCGR2B/CR2";2
"GO:0002923";"GO:0002923";"regulation of humoral immune response mediated by circulating immunoglobulin";"2/19";"18/18888";0,111111111111111;110,456140350877;14,7426067388548;0,000145277572792027;0,00211638933203199;0,000904326931349978;"FCGR2B/CR2";2
"GO:0042113";"GO:0042113";"B cell activation";"4/19";"278/18888";0,0143884892086331;14,3036728511927;7,09095315751759;0,000149529200735113;0,00215176166911504;0,000919441426856472;"CD81/TLR4/FCGR2B/CR2";4
"GO:0032760";"GO:0032760";"positive regulation of tumor necrosis factor production";"3/19";"109/18888";0,0275229357798165;27,3606953162723;8,75825786698075;0,000169359008301888;0,00240775457585816;0,00102882644231584;"FCGR2A/TLR4/FCGR2B";3
"GO:0031341";"GO:0031341";"regulation of cell killing";"3/19";"110/18888";0,0272727272727273;27,111961722488;8,71555452202652;0,00017399676691936;0,00244424029720054;0,00104441668363877;"CFH/FCGR2B/ITGAM";3
"GO:0002755";"GO:0002755";"MyD88-dependent toll-like receptor signaling pathway";"2/19";"20/18888";0,1;99,4105263157895;13,9726077359532;0,000180193724284896;0,00247242551925788;0,00105646014605221;"IRAK1/TLR4";2
"GO:0071514";"GO:0071514";"genomic imprinting";"2/19";"20/18888";0,1;99,4105263157895;13,9726077359532;0,000180193724284896;0,00247242551925788;0,00105646014605221;"DNMT3A/MECP2";2
"GO:1903557";"GO:1903557";"positive regulation of tumor necrosis factor superfamily cytokine production";"3/19";"113/18888";0,0265486725663717;26,3921751280857;8,59078800388704;0,000188403772474728;0,0025553615117262;0,00109189845148693;"FCGR2A/TLR4/FCGR2B";3
"GO:0032355";"GO:0032355";"response to estradiol";"3/19";"115/18888";0,0260869565217391;25,933180778032;8,51027539858232;0,000198426296351868;0,00260966238073665;0,00111510105296419;"DNMT3A/MECP2/ITGAM";3
"GO:0002888";"GO:0002888";"positive regulation of myeloid leukocyte mediated immunity";"2/19";"21/18888";0,0952380952380952;94,6766917293233;13,6293020345925;0,000199042045988389;0,00260966238073665;0,00111510105296419;"C3/ITGAM";2
"GO:0010288";"GO:0010288";"response to lead ion";"2/19";"21/18888";0,0952380952380952;94,6766917293233;13,6293020345925;0,000199042045988389;0,00260966238073665;0,00111510105296419;"DNMT3A/MECP2";2
"GO:0002366";"GO:0002366";"leukocyte activation involved in immune response";"4/19";"301/18888";0,0132890365448505;13,2107011715335;6,77646266235656;0,000202840652425227;0,0026302414270524;0,00112389441887431;"CD81/TLR4/FCGR2B/ITGAM";4
"GO:0002263";"GO:0002263";"cell activation involved in immune response";"4/19";"305/18888";0,0131147540983607;13,0374460742019;6,7252775028529;0,000213350178217085;0,00273644793800174;0,00116927614835222;"CD81/TLR4/FCGR2B/ITGAM";4
"GO:0097062";"GO:0097062";"dendritic spine maintenance";"2/19";"22/18888";0,0909090909090909;90,3732057416268;13,3095266369236;0,000218814951448525;0,00277636174956193;0,0011863312025336;"APOE/FCGR2B";2
"GO:0046651";"GO:0046651";"lymphocyte proliferation";"4/19";"308/18888";0,012987012987013;12,9104579630895;6,68751566700272;0,000221486873191929;0,00278036713155826;0,00118804269046959;"CD81/TLR4/FCGR2B/CR2";4
"GO:0002718";"GO:0002718";"regulation of cytokine production involved in immune response";"3/19";"120/18888";0,025;24,8526315789474;8,31767169209441;0,000224982203489509;0,00279063303561642;0,00119242928105287;"CD81/TLR4/TLR7";3
"GO:0002440";"GO:0002440";"production of molecular mediator of immune response";"4/19";"310/18888";0,0129032258064516;12,8271646859083;6,66263251880814;0,00022703455205015;0,00279063303561642;0,00119242928105287;"CD81/TLR4/FCGR2B/TLR7";4
"GO:0044403";"GO:0044403";"biological process involved in symbiotic interaction";"4/19";"311/18888";0,0128617363344051;12,7859197833813;6,65027697203298;0,000229845757807877;0,00279606179601335;0,00119474897438929;"CD81/APOE/SCARB2/CR2";4
"GO:0002367";"GO:0002367";"cytokine production involved in immune response";"3/19";"122/18888";0,0245901639344262;24,4452113891286;8,24388757598531;0,000236217650145816;0,00284425333849044;0,00121534107862348;"CD81/TLR4/TLR7";3
"GO:0032943";"GO:0032943";"mononuclear cell proliferation";"4/19";"315/18888";0,0126984126984127;12,6235588972431;6,60141774832956;0,000241342825033704;0,00287661144989667;0,00122916760437155;"CD81/TLR4/FCGR2B/CR2";4
"GO:0032479";"GO:0032479";"regulation of type I interferon production";"3/19";"124/18888";0,0241935483870968;24,0509337860781;8,17185217891929;0,000247810938998901;0,00289521691107627;0,00123711766316283;"IRAK1/TLR4/TLR7";3
"GO:0032606";"GO:0032606";"type I interferon production";"3/19";"124/18888";0,0241935483870968;24,0509337860781;8,17185217891929;0,000247810938998901;0,00289521691107627;0,00123711766316283;"IRAK1/TLR4/TLR7";3
"GO:0019058";"GO:0019058";"viral life cycle";"4/19";"319/18888";0,0125391849529781;12,4652697574658;6,55343821301041;0,000253249957845354;0,00290689422030818;0,00124210734302196;"CD81/APOE/SCARB2/CR2";4
"GO:0002922";"GO:0002922";"positive regulation of humoral immune response";"2/19";"24/18888";0,0833333333333333;82,8421052631579;12,730614513576;0,000261127785892091;0,00290689422030818;0,00124210734302196;"C3/FCGR2B";2
"GO:0032727";"GO:0032727";"positive regulation of interferon-alpha production";"2/19";"24/18888";0,0833333333333333;82,8421052631579;12,730614513576;0,000261127785892091;0,00290689422030818;0,00124210734302196;"TLR4/TLR7";2
"GO:0050855";"GO:0050855";"regulation of B cell receptor signaling pathway";"2/19";"24/18888";0,0833333333333333;82,8421052631579;12,730614513576;0,000261127785892091;0,00290689422030818;0,00124210734302196;"CD81/FCGR2B";2
"GO:0060907";"GO:0060907";"positive regulation of macrophage cytokine production";"2/19";"24/18888";0,0833333333333333;82,8421052631579;12,730614513576;0,000261127785892091;0,00290689422030818;0,00124210734302196;"TLR4/TLR7";2
"GO:0002456";"GO:0002456";"T cell mediated immunity";"3/19";"129/18888";0,0232558139534884;23,1187270501836;7,99896858616407;0,000278392239226234;0,00307012002137342;0,00131185324731299;"CD81/FCGR2B/CR2";3
"GO:0050864";"GO:0050864";"regulation of B cell activation";"3/19";"130/18888";0,0230769230769231;22,9408906882591;7,96556365472116;0,000284787374798594;0,00311156576168834;0,00132956289014158;"CD81/TLR4/FCGR2B";3
"GO:0021782";"GO:0021782";"glial cell development";"3/19";"133/18888";0,0225563909774436;22,4234269885239;7,86756026751095;0,000304541512447561;0,00327995560825633;0,00140151537587402;"TLR4/C1QA/MECP2";3
"GO:0098581";"GO:0098581";"detection of external biotic stimulus";"2/19";"26/18888";0,0769230769230769;76,4696356275304;12,2193725312559;0,00030711879358174;0,00327995560825633;0,00140151537587402;"TLR4/C4B";2
"GO:0002702";"GO:0002702";"positive regulation of production of molecular mediator of immune response";"3/19";"134/18888";0,0223880597014925;22,2560879811469;7,83560673286261;0,000311317820444669;0,00327995560825633;0,00140151537587402;"CD81/TLR4/TLR7";3
"GO:0043405";"GO:0043405";"regulation of MAP kinase activity";"3/19";"134/18888";0,0223880597014925;22,2560879811469;7,83560673286261;0,000311317820444669;0,00327995560825633;0,00140151537587402;"APOE/IRAK1/TLR4";3
"GO:0070661";"GO:0070661";"leukocyte proliferation";"4/19";"352/18888";0,0113636363636364;11,2966507177034;6,1878980621179;0,000368271523250789;0,00384566723394629;0,00164324228818936;"CD81/TLR4/FCGR2B/CR2";4
"GO:0032607";"GO:0032607";"interferon-alpha production";"2/19";"30/18888";0,0666666666666667;66,2736842105263;11,3536312832062;0,000410081763911239;0,00420779549056749;0,00179797862621037;"TLR4/TLR7";2
"GO:0032647";"GO:0032647";"regulation of interferon-alpha production";"2/19";"30/18888";0,0666666666666667;66,2736842105263;11,3536312832062;0,000410081763911239;0,00420779549056749;0,00179797862621037;"TLR4/TLR7";2
"GO:0002705";"GO:0002705";"positive regulation of leukocyte mediated immunity";"3/19";"150/18888";0,02;19,8821052631579;7,36746828506942;0,00043330785895915;0,00440778684113618;0,0018834343415738;"CD81/C3/ITGAM";3
"GO:0002237";"GO:0002237";"response to molecule of bacterial origin";"4/19";"369/18888";0,010840108401084;10,7762088147197;6,01809078494885;0,000440276422351713;0,004440394686966;0,0018973675781059;"IRAK1/TLR4/FCGR2B/C4B";4
"GO:0046718";"GO:0046718";"symbiont entry into host cell";"3/19";"156/18888";0,0192307692307692;19,1174089068826;7,21024728052343;0,000485935092140551;0,00485935092140551;0,00207638634375847;"CD81/SCARB2/CR2";3
"GO:0002753";"GO:0002753";"cytoplasmic pattern recognition receptor signaling pathway";"3/19";"163/18888";0,0184049079754601;18,2964158863416;7,03757208986213;0,000552328779244183;0,00543123299590113;0,00232074987068389;"IRAK1/TLR4/TLR7";3
"GO:0044409";"GO:0044409";"symbiont entry into host";"3/19";"163/18888";0,0184049079754601;18,2964158863416;7,03757208986213;0,000552328779244183;0,00543123299590113;0,00232074987068389;"CD81/SCARB2/CR2";3
"GO:0061081";"GO:0061081";"positive regulation of myeloid leukocyte cytokine production involved in immune response";"2/19";"35/18888";0,0571428571428571;56,806015037594;10,485970910604;0,000559237243089009;0,0054537185689672;0,00233035788986199;"TLR4/TLR7";2
"GO:0010934";"GO:0010934";"macrophage cytokine production";"2/19";"37/18888";0,0540540540540541;53,7354196301565;10,1887268617126;0,000625219598689599;0,00594967037462683;0,00254227663643733;"TLR4/TLR7";2
"GO:0010935";"GO:0010935";"regulation of macrophage cytokine production";"2/19";"37/18888";0,0540540540540541;53,7354196301565;10,1887268617126;0,000625219598689599;0,00594967037462683;0,00254227663643733;"TLR4/TLR7";2
"GO:0071404";"GO:0071404";"cellular response to low-density lipoprotein particle stimulus";"2/19";"37/18888";0,0540540540540541;53,7354196301565;10,1887268617126;0,000625219598689599;0,00594967037462683;0,00254227663643733;"CD81/TLR4";2
"GO:0048660";"GO:0048660";"regulation of smooth muscle cell proliferation";"3/19";"174/18888";0,0172413793103448;17,1397459165154;6,78690630103326;0,000667969943375778;0,00630563626546734;0,00269437981370103;"APOE/IRAK1/TLR4";3
"GO:0007616";"GO:0007616";"long-term memory";"2/19";"39/18888";0,0512820512820513;50,9797570850202;9,91439312882108;0,000694793638743108;0,00645556294265249;0,00275844304150807;"APOE/MECP2";2
"GO:0060999";"GO:0060999";"positive regulation of dendritic spine development";"2/19";"39/18888";0,0512820512820513;50,9797570850202;9,91439312882108;0,000694793638743108;0,00645556294265249;0,00275844304150807;"APOE/MECP2";2
"GO:0048659";"GO:0048659";"smooth muscle cell proliferation";"3/19";"178/18888";0,0168539325842697;16,7545830869308;6,70137422207797;0,000713567489866254;0,00657820029720453;0,00281084562208829;"APOE/IRAK1/TLR4";3
"GO:0009595";"GO:0009595";"detection of biotic stimulus";"2/19";"40/18888";0,05;49,7052631578947;9,78491599933542;0,000730923420785826;0,00663453566559442;0,00283491755916122;"TLR4/C4B";2
"GO:0032728";"GO:0032728";"positive regulation of interferon-beta production";"2/19";"40/18888";0,05;49,7052631578947;9,78491599933542;0,000730923420785826;0,00663453566559442;0,00283491755916122;"TLR4/TLR7";2
"GO:0016032";"GO:0016032";"viral process";"4/19";"428/18888";0,00934579439252336;9,29070339399902;5,50530345863411;0,000769096536636433;0,00692773979565642;0,00296020282080234;"CD81/APOE/SCARB2/CR2";4
"GO:0001662";"GO:0001662";"behavioral fear response";"2/19";"42/18888";0,0476190476190476;47,3383458646616;9,53980345012898;0,000805860288055577;0,00714973789402692;0,00305506195471802;"APOE/MECP2";2
"GO:0042119";"GO:0042119";"neutrophil activation";"2/19";"42/18888";0,0476190476190476;47,3383458646616;9,53980345012898;0,000805860288055577;0,00714973789402692;0,00305506195471802;"FCGR2B/ITGAM";2
"GO:0002209";"GO:0002209";"behavioral defense response";"2/19";"43/18888";0,0465116279069767;46,2374541003672;9,42362858275783;0,000844664091261979;0,00731334153807144;0,0031249693102018;"APOE/MECP2";2
"GO:1904646";"GO:1904646";"cellular response to amyloid-beta";"2/19";"43/18888";0,0465116279069767;46,2374541003672;9,42362858275783;0,000844664091261979;0,00731334153807144;0,0031249693102018;"TLR4/FCGR2B";2
"GO:0032640";"GO:0032640";"tumor necrosis factor production";"3/19";"189/18888";0,0158730158730159;15,7794486215539;6,47983267932679;0,000849091348064227;0,00731334153807144;0,0031249693102018;"FCGR2A/TLR4/FCGR2B";3
"GO:0032680";"GO:0032680";"regulation of tumor necrosis factor production";"3/19";"189/18888";0,0158730158730159;15,7794486215539;6,47983267932679;0,000849091348064227;0,00731334153807144;0,0031249693102018;"FCGR2A/TLR4/FCGR2B";3
"GO:0014002";"GO:0014002";"astrocyte development";"2/19";"44/18888";0,0454545454545455;45,1866028708134;9,31138432735786;0,00088435595634065;0,00750748221929473;0,00320792505177714;"TLR4/C1QA";2
"GO:0030890";"GO:0030890";"positive regulation of B cell proliferation";"2/19";"44/18888";0,0454545454545455;45,1866028708134;9,31138432735786;0,00088435595634065;0,00750748221929473;0,00320792505177714;"CD81/TLR4";2
"GO:0071706";"GO:0071706";"tumor necrosis factor superfamily cytokine production";"3/19";"194/18888";0,0154639175257732;15,3727618014107;6,38518996297705;0,000915742696640067;0,00766366228393815;0,00327466033363637;"FCGR2A/TLR4/FCGR2B";3
"GO:1903555";"GO:1903555";"regulation of tumor necrosis factor superfamily cytokine production";"3/19";"194/18888";0,0154639175257732;15,3727618014107;6,38518996297705;0,000915742696640067;0,00766366228393815;0,00327466033363637;"FCGR2A/TLR4/FCGR2B";3
"GO:0043300";"GO:0043300";"regulation of leukocyte degranulation";"2/19";"45/18888";0,0444444444444444;44,1824561403509;9,20285166179487;0,000924934247535417;0,00768607332459008;0,00328423650533332;"FCGR2B/ITGAM";2
"GO:0090207";"GO:0090207";"regulation of triglyceride metabolic process";"2/19";"46/18888";0,0434782608695652;43,2219679633867;9,09782830212628;0,000966397331187739;0,0079744674881226;0,00340746648243597;"APOE/C3";2
"GO:0140894";"GO:0140894";"endolysosomal toll-like receptor signaling pathway";"2/19";"47/18888";0,0425531914893617;42,3023516237402;8,99612709228669;0,00100874357573447;0,00826609319004635;0,0035320772863802;"IRAK1/TLR7";2
"GO:0051701";"GO:0051701";"biological process involved in interaction with host";"3/19";"202/18888";0,0148514851485149;14,7639395518499;6,24085536199276;0,00102915956685829;0,00827550796675095;0,00353610019275085;"CD81/SCARB2/CR2";3
"GO:0001774";"GO:0001774";"microglial cell activation";"2/19";"48/18888";0,0416666666666667;41,4210526315789;8,89757457920272;0,00105197135170563;0,00827550796675095;0,00353610019275085;"C1QA/ITGAM";2
"GO:0002673";"GO:0002673";"regulation of acute inflammatory response";"2/19";"48/18888";0,0416666666666667;41,4210526315789;8,89757457920272;0,00105197135170563;0,00827550796675095;0,00353610019275085;"C3/FCGR2B";2
"GO:0006305";"GO:0006305";"DNA alkylation";"2/19";"48/18888";0,0416666666666667;41,4210526315789;8,89757457920272;0,00105197135170563;0,00827550796675095;0,00353610019275085;"DNMT3A/MECP2";2
"GO:0006306";"GO:0006306";"DNA methylation";"2/19";"48/18888";0,0416666666666667;41,4210526315789;8,89757457920272;0,00105197135170563;0,00827550796675095;0,00353610019275085;"DNMT3A/MECP2";2
"GO:0042596";"GO:0042596";"fear response";"2/19";"48/18888";0,0416666666666667;41,4210526315789;8,89757457920272;0,00105197135170563;0,00827550796675095;0,00353610019275085;"APOE/MECP2";2
"GO:0048469";"GO:0048469";"cell maturation";"3/19";"205/18888";0,0146341463414634;14,5478818998716;6,188834572553;0,0010738840851743;0,0083919418576535;0,0035858520515754;"C3/C1QA/MECP2";3
"GO:0036230";"GO:0036230";"granulocyte activation";"2/19";"49/18888";0,0408163265306122;40,5757250268528;8,80200974861689;0,00109607903172217;0,00850903458836948;0,00363588543071274;"FCGR2B/ITGAM";2
"GO:0061082";"GO:0061082";"myeloid leukocyte cytokine production";"2/19";"50/18888";0,04;39,7642105263158;8,70928290062637;0,00114106499049375;0,00880037051491912;0,00376037241449265;"TLR4/TLR7";2
"GO:0002285";"GO:0002285";"lymphocyte activation involved in immune response";"3/19";"212/18888";0,0141509433962264;14,0675273088381;6,07160154211914;0,00118299547417071;0,00897804213899669;0,00383629097643124;"CD81/TLR4/FCGR2B";3
"GO:0002269";"GO:0002269";"leukocyte activation involved in inflammatory response";"2/19";"51/18888";0,0392156862745098;38,984520123839;8,61925464704529;0,00118692760481651;0,00897804213899669;0,00383629097643124;"C1QA/ITGAM";2
"GO:0042220";"GO:0042220";"response to cocaine";"2/19";"51/18888";0,0392156862745098;38,984520123839;8,61925464704529;0,00118692760481651;0,00897804213899669;0,00383629097643124;"DNMT3A/MECP2";2
"GO:0010543";"GO:0010543";"regulation of platelet activation";"2/19";"52/18888";0,0384615384615385;38,2348178137652;8,53179501529154;0,00123366525357085;0,00927213375295287;0,00396195545732777;"APOE/TLR4";2
"GO:0009612";"GO:0009612";"response to mechanical stimulus";"3/19";"216/18888";0,0138888888888889;13,8070175438596;6,007078524354;0,00124838214058952;0,00932336029047869;0,00398384440601186;"TLR4/TLR7/ITGAM";3
"GO:1904645";"GO:1904645";"response to amyloid-beta";"2/19";"54/18888";0,037037037037037;36,8187134502924;8,36410407079056;0,00132975918030379;0,00986865303621682;0,00421684639103288;"TLR4/FCGR2B";2
"GO:0002823";"GO:0002823";"negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains";"2/19";"56/18888";0,0357142857142857;35,5037593984962;8,20533007151936;0,00142933384333652;0,0105413370946068;0,00450428230893547;"FCGR2B/CR2";2
"GO:0002707";"GO:0002707";"negative regulation of lymphocyte mediated immunity";"2/19";"57/18888";0,0350877192982456;34,8808864265928;8,12904165189789;0,00148042242024827;0,0107171684410611;0,00457941452566303;"FCGR2B/CR2";2
"GO:0031663";"GO:0031663";"lipopolysaccharide-mediated signaling pathway";"2/19";"57/18888";0,0350877192982456;34,8808864265928;8,12904165189789;0,00148042242024827;0,0107171684410611;0,00457941452566303;"IRAK1/TLR4";2
"GO:0061900";"GO:0061900";"glial cell activation";"2/19";"57/18888";0,0350877192982456;34,8808864265928;8,12904165189789;0,00148042242024827;0,0107171684410611;0,00457941452566303;"C1QA/ITGAM";2
"GO:0060998";"GO:0060998";"regulation of dendritic spine development";"2/19";"58/18888";0,0344827586206897;34,2794918330309;8,05470003136211;0,00153237634851909;0,0110256347027593;0,00471122125122366;"APOE/MECP2";2
"GO:0032608";"GO:0032608";"interferon-beta production";"2/19";"59/18888";0,0338983050847458;33,6984834968778;7,98222265461709;0,00158519402155711;0,0112682466592614;0,00481488862603585;"TLR4/TLR7";2
"GO:0032648";"GO:0032648";"regulation of interferon-beta production";"2/19";"59/18888";0,0338983050847458;33,6984834968778;7,98222265461709;0,00158519402155711;0,0112682466592614;0,00481488862603585;"TLR4/TLR7";2
"GO:0050670";"GO:0050670";"regulation of lymphocyte proliferation";"3/19";"237/18888";0,0126582278481013;12,5836109260493;5,69443870073546;0,00162920012329492;0,0113757125006329;0,00486080846369595;"CD81/TLR4/FCGR2B";3
"GO:0043030";"GO:0043030";"regulation of macrophage activation";"2/19";"60/18888";0,0333333333333333;33,1368421052632;7,91153179515814;0,00163887383483694;0,0113757125006329;0,00486080846369595;"TLR4/FCGR2B";2
"GO:0043113";"GO:0043113";"receptor clustering";"2/19";"60/18888";0,0333333333333333;33,1368421052632;7,91153179515814;0,00163887383483694;0,0113757125006329;0,00486080846369595;"CD81/APOE";2
"GO:0061462";"GO:0061462";"protein localization to lysosome";"2/19";"60/18888";0,0333333333333333;33,1368421052632;7,91153179515814;0,00163887383483694;0,0113757125006329;0,00486080846369595;"CD81/SCARB2";2
"GO:0071219";"GO:0071219";"cellular response to molecule of bacterial origin";"3/19";"238/18888";0,0126050420168067;12,530738611234;5,68054541287825;0,00164895030979102;0,0113787214359848;0,00486209417291412;"IRAK1/TLR4/FCGR2B";3
"GO:0002820";"GO:0002820";"negative regulation of adaptive immune response";"2/19";"61/18888";0,0327868852459016;32,5936151855047;7,84255419786228;0,00169341418589759;0,0116176089497625;0,00496417010431424;"FCGR2B/CR2";2
"GO:0032944";"GO:0032944";"regulation of mononuclear cell proliferation";"3/19";"241/18888";0,012448132780083;12,3747543131688;5,63936116474312;0,00170910431660314;0,0116574745294318;0,00498120454915062;"CD81/TLR4/FCGR2B";3
"GO:0050807";"GO:0050807";"regulation of synapse organization";"3/19";"243/18888";0,0123456790123457;12,2729044834308;5,61230957290257;0,00174996415896804;0,0118675730320821;0,00507097902084508;"APOE/FCGR2B/MECP2";3
"GO:0032757";"GO:0032757";"positive regulation of interleukin-8 production";"2/19";"63/18888";0,0317460317460317;31,5588972431078;7,70946620116457;0,00180507010182571;0,0121713298294533;0,00520077340616249;"TLR4/TLR7";2
"GO:0034142";"GO:0034142";"toll-like receptor 4 signaling pathway";"2/19";"64/18888";0,03125;31,0657894736842;7,64522885783426;0,001862182472073;0,0124850870286713;0,00533484093374981;"IRAK1/TLR4";2
"GO:0050803";"GO:0050803";"regulation of synapse structure or activity";"3/19";"249/18888";0,0120481927710843;11,9771718452758;5,53302561564415;0,00187621554481132;0,0125081036320755;0,00534467586062815;"APOE/FCGR2B/MECP2";3
"GO:0033002";"GO:0033002";"muscle cell proliferation";"3/19";"251/18888";0,0119521912350598;11,8817362130426;5,50720065606687;0,00191953451066271;0,0125876433845029;0,00537866296269123;"APOE/IRAK1/TLR4";3
"GO:0032613";"GO:0032613";"interleukin-10 production";"2/19";"65/18888";0,0307692307692308;30,5878542510121;7,58245036895877;0,00192014899085637;0,0125876433845029;0,00537866296269123;"TLR4/FCGR2B";2
"GO:0032653";"GO:0032653";"regulation of interleukin-10 production";"2/19";"65/18888";0,0307692307692308;30,5878542510121;7,58245036895877;0,00192014899085637;0,0125876433845029;0,00537866296269123;"TLR4/FCGR2B";2
"GO:1901224";"GO:1901224";"positive regulation of non-canonical NF-kappaB signal transduction";"2/19";"66/18888";0,0303030303030303;30,1244019138756;7,52107548133016;0,00197896806600346;0,0129015597673154;0,00551279850895991;"TLR4/TLR7";2
"GO:0002221";"GO:0002221";"pattern recognition receptor signaling pathway";"3/19";"259/18888";0,0115830115830116;11,5147327778907;5,40676133084844;0,0020990745722337;0,0134619884880682;0,00575226805154742;"IRAK1/TLR4/TLR7";3
"GO:0002704";"GO:0002704";"negative regulation of leukocyte mediated immunity";"2/19";"68/18888";0,0294117647058824;29,2383900928793;7,40232976680963;0,002099157526953;0,0134619884880682;0,00575226805154742;"FCGR2B/CR2";2
"GO:0050854";"GO:0050854";"regulation of antigen receptor-mediated signaling pathway";"2/19";"68/18888";0,0294117647058824;29,2383900928793;7,40232976680963;0,002099157526953;0,0134619884880682;0,00575226805154742;"CD81/FCGR2B";2
"GO:0010001";"GO:0010001";"glial cell differentiation";"3/19";"260/18888";0,0115384615384615;11,4704453441296;5,39451694802671;0,0021222285338918;0,0135363765945531;0,00578405387046469;"TLR4/C1QA/MECP2";3
"GO:2000379";"GO:2000379";"positive regulation of reactive oxygen species metabolic process";"2/19";"70/18888";0,0285714285714286;28,403007518797;7,28860418676825;0,00222273815852647;0,0141012420809744;0,0060254192299614;"TLR4/ITGAM";2
"GO:0071216";"GO:0071216";"cellular response to biotic stimulus";"3/19";"265/18888";0,0113207547169811;11,2540218470705;5,33428483655939;0,00224039801266026;0,0141372708820273;0,00604081423058973;"IRAK1/TLR4/FCGR2B";3
"GO:0070663";"GO:0070663";"regulation of leukocyte proliferation";"3/19";"267/18888";0,0112359550561798;11,1697220579539;5,31064245077684;0,00228879305265462;0,0142898190589018;0,00610599761749686;"CD81/TLR4/FCGR2B";3
"GO:0071900";"GO:0071900";"regulation of protein serine/threonine kinase activity";"3/19";"267/18888";0,0112359550561798;11,1697220579539;5,31064245077684;0,00228879305265462;0,0142898190589018;0,00610599761749686;"APOE/IRAK1/TLR4";3
"GO:0032722";"GO:0032722";"positive regulation of chemokine production";"2/19";"72/18888";0,0277777777777778;27,6140350877193;7,17954909328605;0,00234969729704201;0,014440847971404;0,0061705318272101;"TLR4/TLR7";2
"GO:0043954";"GO:0043954";"cellular component maintenance";"2/19";"72/18888";0,0277777777777778;27,6140350877193;7,17954909328605;0,00234969729704201;0,014440847971404;0,0061705318272101;"APOE/FCGR2B";2
"GO:0140895";"GO:0140895";"cell surface toll-like receptor signaling pathway";"2/19";"72/18888";0,0277777777777778;27,6140350877193;7,17954909328605;0,00234969729704201;0,014440847971404;0,0061705318272101;"IRAK1/TLR4";2
"GO:0071695";"GO:0071695";"anatomical structure maturation";"3/19";"271/18888";0,011070110701107;11,004855311711;5,26410395134629;0,00238753282013956;0,0145973509210605;0,0062374050768849;"C3/C1QA/MECP2";3
"GO:0071260";"GO:0071260";"cellular response to mechanical stimulus";"2/19";"73/18888";0,0273972602739726;27,2357606344629;7,12667291679719;0,00241443985793034;0,0146857682080299;0,0062751855233241;"TLR4/TLR7";2
"GO:0050795";"GO:0050795";"regulation of behavior";"2/19";"74/18888";0,027027027027027;26,8677098150782;7,07484808337194;0,00248002231146125;0,0150073145001245;0,00641258130736809;"APOE/MECP2";2
"GO:0002758";"GO:0002758";"innate immune response-activating signaling pathway";"3/19";"278/18888";0,0107913669064748;10,7277546383945;5,18496307299799;0,00256664705593694;0,0154522628877836;0,00660270644357569;"IRAK1/TLR4/TLR7";3
"GO:0032729";"GO:0032729";"positive regulation of type II interferon production";"2/19";"77/18888";0,025974025974026;25,8209159261791;6,92533956660563;0,00268179330015781;0,0160635334730265;0,00686390056519152;"TLR4/TLR7";2
"GO:0050853";"GO:0050853";"B cell receptor signaling pathway";"2/19";"78/18888";0,0256410256410256;25,4898785425101;6,87738573057765;0,00275071960665625;0,01639317745381;0,00700475646777428;"CD81/FCGR2B";2
"GO:0002752";"GO:0002752";"cell surface pattern recognition receptor signaling pathway";"2/19";"79/18888";0,0253164556962025;25,1672218520986;6,83032344211442;0,00282047795713709;0,0166408199471089;0,00711057337615088;"IRAK1/TLR4";2
"GO:0043299";"GO:0043299";"leukocyte degranulation";"2/19";"79/18888";0,0253164556962025;25,1672218520986;6,83032344211442;0,00282047795713709;0,0166408199471089;0,00711057337615088;"FCGR2B/ITGAM";2
"GO:0010721";"GO:0010721";"negative regulation of cell development";"3/19";"288/18888";0,0104166666666667;10,3552631578947;5,07667812234323;0,0028367018966045;0,0166532748158871;0,0071158953049152;"TLR4/FCGR2B/MECP2";3
"GO:0097061";"GO:0097061";"dendritic spine organization";"2/19";"81/18888";0,0246913580246914;24,5458089668616;6,73876345091715;0,00296248453744721;0,0173056027435035;0,00739463310806259;"APOE/FCGR2B";2
"GO:0043406";"GO:0043406";"positive regulation of MAP kinase activity";"2/19";"82/18888";0,024390243902439;24,2464698331194;6,69421366137961;0,00303472964602654;0,0175538283446633;0,00750069917671162;"IRAK1/TLR4";2
"GO:0043537";"GO:0043537";"negative regulation of blood vessel endothelial cell migration";"2/19";"82/18888";0,024390243902439;24,2464698331194;6,69421366137961;0,00303472964602654;0,0175538283446633;0,00750069917671162;"APOE/MECP2";2
"GO:0050871";"GO:0050871";"positive regulation of B cell activation";"2/19";"83/18888";0,0240963855421687;23,9543436905517;6,65045111788754;0,00310780055608412;0,0178019643503847;0,00760672696149357;"CD81/TLR4";2
"GO:0150076";"GO:0150076";"neuroinflammatory response";"2/19";"83/18888";0,0240963855421687;23,9543436905517;6,65045111788754;0,00310780055608412;0,0178019643503847;0,00760672696149357;"C1QA/ITGAM";2
"GO:0002218";"GO:0002218";"activation of innate immune response";"3/19";"298/18888";0,0100671140939597;10,0077711056164;4,97358594915834;0,00312376658649937;0,0178069786090302;0,0076088695394518;"IRAK1/TLR4/TLR7";3
"GO:0002312";"GO:0002312";"B cell activation involved in immune response";"2/19";"87/18888";0,0229885057471264;22,8529945553539;6,48281991425648;0,00340831112956047;0,0193356112157757;0,00826204975232523;"TLR4/FCGR2B";2
"GO:0072665";"GO:0072665";"protein localization to vacuole";"2/19";"88/18888";0,0227272727272727;22,5933014354067;6,44266140072471;0,0034854877534396;0,0196788303782714;0,00840870629009099;"CD81/SCARB2";2
"GO:0007249";"GO:0007249";"canonical NF-kappaB signal transduction";"3/19";"311/18888";0,00964630225080386;9,58943983753596;4,84664370741544;0,00352296223437113;0,0197956925550378;0,00845864115420437;"IRAK1/TLR4/TLR7";3
"GO:0001666";"GO:0001666";"response to hypoxia";"3/19";"313/18888";0,00958466453674121;9,52816546157726;4,82777724927809;0,00358702957113559;0,0200601653741232;0,00857164961124444;"IRAK1/DNMT3A/MECP2";3
"GO:0106027";"GO:0106027";"neuron projection organization";"2/19";"92/18888";0,0217391304347826;21,6109839816934;6,28845228073853;0,00380234380454084;0,0211639891007462;0,00904331024019395;"APOE/FCGR2B";2
"GO:0019915";"GO:0019915";"lipid storage";"2/19";"94/18888";0,0212765957446809;21,1511758118701;6,21496312262842;0,00396564000274619;0,0218524348932438;0,00933748110068136;"APOE/C3";2
"GO:0019216";"GO:0019216";"regulation of lipid metabolic process";"3/19";"326/18888";0,00920245398773006;9,14820794317081;4,70914830608724;0,00402100931812234;0,0218524348932438;0,00933748110068136;"APOE/C3/SCARB2";3
"GO:1904951";"GO:1904951";"positive regulation of establishment of protein localization";"3/19";"326/18888";0,00920245398773006;9,14820794317081;4,70914830608724;0,00402100931812234;0,0218524348932438;0,00933748110068136;"CD81/TLR4/ITGAM";3
"GO:0033555";"GO:0033555";"multicellular organismal response to stress";"2/19";"95/18888";0,0210526315789474;20,9285318559557;6,17906692951028;0,00404849976879948;0,0218524348932438;0,00933748110068136;"APOE/MECP2";2
"GO:0043279";"GO:0043279";"response to alkaloid";"2/19";"95/18888";0,0210526315789474;20,9285318559557;6,17906692951028;0,00404849976879948;0,0218524348932438;0,00933748110068136;"DNMT3A/MECP2";2
"GO:0046330";"GO:0046330";"positive regulation of JNK cascade";"2/19";"95/18888";0,0210526315789474;20,9285318559557;6,17906692951028;0,00404849976879948;0,0218524348932438;0,00933748110068136;"TLR4/FCGR2B";2
"GO:0036293";"GO:0036293";"response to decreased oxygen levels";"3/19";"327/18888";0,00917431192660551;9,12023177209078;4,70029877344426;0,00405566376408509;0,0218524348932438;0,00933748110068136;"IRAK1/DNMT3A/MECP2";3
"GO:0001910";"GO:0001910";"regulation of leukocyte mediated cytotoxicity";"2/19";"96/18888";0,0208333333333333;20,7105263157895;6,14371674077237;0,00413216527004687;0,0220631448807933;0,00942751685807312;"FCGR2B/ITGAM";2
"GO:0060996";"GO:0060996";"dendritic spine development";"2/19";"96/18888";0,0208333333333333;20,7105263157895;6,14371674077237;0,00413216527004687;0,0220631448807933;0,00942751685807312;"APOE/MECP2";2
"GO:0006576";"GO:0006576";"biogenic amine metabolic process";"2/19";"98/18888";0,0204081632653061;20,2878625134264;6,07459876987067;0,0043019073617229;0,0228659940848335;0,00977057195953187;"MECP2/ITGAM";2
"GO:0002709";"GO:0002709";"regulation of T cell mediated immunity";"2/19";"99/18888";0,0202020202020202;20,0829346092504;6,04080441407636;0,00438798089890933;0,023218912379879;0,00992137290808387;"CD81/FCGR2B";2
"GO:0002220";"GO:0002220";"innate immune response activating cell surface receptor signaling pathway";"2/19";"100/18888";0,02;19,8821052631579;6,00750287106162;0,00447485406480116;0,023364282285245;0,00998348904070683;"IRAK1/TLR4";2
"GO:0006304";"GO:0006304";"DNA modification";"2/19";"100/18888";0,02;19,8821052631579;6,00750287106162;0,00447485406480116;0,023364282285245;0,00998348904070683;"DNMT3A/MECP2";2
"GO:0048661";"GO:0048661";"positive regulation of smooth muscle cell proliferation";"2/19";"100/18888";0,02;19,8821052631579;6,00750287106162;0,00447485406480116;0,023364282285245;0,00998348904070683;"IRAK1/TLR4";2
"GO:0021700";"GO:0021700";"developmental maturation";"3/19";"341/18888";0,00879765395894428;8,7457941040284;4,58026019905157;0,00456020140180536;0,0235099558887194;0,0100457349426374;"C3/C1QA/MECP2";3
"GO:0010596";"GO:0010596";"negative regulation of endothelial cell migration";"2/19";"101/18888";0,0198019801980198;19,6852527357999;5,97468198601667;0,00456252533772605;0,0235099558887194;0,0100457349426374;"APOE/MECP2";2
"GO:0032755";"GO:0032755";"positive regulation of interleukin-6 production";"2/19";"101/18888";0,0198019801980198;19,6852527357999;5,97468198601667;0,00456252533772605;0,0235099558887194;0,0100457349426374;"TLR4/TLR7";2
"GO:0032677";"GO:0032677";"regulation of interleukin-8 production";"2/19";"102/18888";0,0196078431372549;19,4922600619195;5,94233002113842;0,00465099319798731;0,0238616172766305;0,010195998818471;"TLR4/TLR7";2
"GO:0015914";"GO:0015914";"phospholipid transport";"2/19";"103/18888";0,0194174757281553;19,3030148185999;5,9104356373939;0,00474025612786179;0,0239492275957842;0,0102334344499381;"APOE/SCARB2";2
"GO:0032637";"GO:0032637";"interleukin-8 production";"2/19";"103/18888";0,0194174757281553;19,3030148185999;5,9104356373939;0,00474025612786179;0,0239492275957842;0,0102334344499381;"TLR4/TLR7";2
"GO:0099175";"GO:0099175";"regulation of postsynapse organization";"2/19";"103/18888";0,0194174757281553;19,3030148185999;5,9104356373939;0,00474025612786179;0,0239492275957842;0,0102334344499381;"APOE/FCGR2B";2
"GO:0042063";"GO:0042063";"gliogenesis";"3/19";"346/18888";0,00867052023121387;8,61940979616672;4,53904973471212;0,00474925360797755;0,0239492275957842;0,0102334344499381;"TLR4/C1QA/MECP2";3
"GO:0032642";"GO:0032642";"regulation of chemokine production";"2/19";"104/18888";0,0192307692307692;19,1174089068826;5,87898787724948;0,00483031261159782;0,0241957089157807;0,0103387551923809;"TLR4/TLR7";2
"GO:0021549";"GO:0021549";"cerebellum development";"2/19";"105/18888";0,019047619047619;18,9353383458647;5,84797614830622;0,00492116113541301;0,0241957089157807;0,0103387551923809;"FCGR2B/MECP2";2
"GO:0031507";"GO:0031507";"heterochromatin formation";"2/19";"105/18888";0,019047619047619;18,9353383458647;5,84797614830622;0,00492116113541301;0,0241957089157807;0,0103387551923809;"DNMT3A/MECP2";2
"GO:0032602";"GO:0032602";"chemokine production";"2/19";"105/18888";0,019047619047619;18,9353383458647;5,84797614830622;0,00492116113541301;0,0241957089157807;0,0103387551923809;"TLR4/TLR7";2
"GO:1901222";"GO:1901222";"regulation of non-canonical NF-kappaB signal transduction";"2/19";"105/18888";0,019047619047619;18,9353383458647;5,84797614830622;0,00492116113541301;0,0241957089157807;0,0103387551923809;"TLR4/TLR7";2
"GO:1905477";"GO:1905477";"positive regulation of protein localization to membrane";"2/19";"105/18888";0,019047619047619;18,9353383458647;5,84797614830622;0,00492116113541301;0,0241957089157807;0,0103387551923809;"CD81/ITGAM";2
"GO:0070482";"GO:0070482";"response to oxygen levels";"3/19";"354/18888";0,00847457627118644;8,42462087421945;4,47481599839689;0,00506157326125344;0,0247828068393322;0,0105896204068155;"IRAK1/DNMT3A/MECP2";3
"GO:0030316";"GO:0030316";"osteoclast differentiation";"2/19";"107/18888";0,0186915887850467;18,581406787998;5,78722014781268;0,00510522825798536;0,0248932617538129;0,0106368174666159;"CD81/TLR4";2
"GO:0006641";"GO:0006641";"triglyceride metabolic process";"2/19";"108/18888";0,0185185185185185;18,4093567251462;5,75745638145279;0,00519844383900534;0,025140015286993;0,0107422545249506;"APOE/C3";2
"GO:0060291";"GO:0060291";"long-term synaptic potentiation";"2/19";"108/18888";0,0185185185185185;18,4093567251462;5,75745638145279;0,00519844383900534;0,025140015286993;0,0107422545249506;"APOE/MECP2";2
"GO:0045089";"GO:0045089";"positive regulation of innate immune response";"3/19";"365/18888";0,00821917808219178;8,17072819033886;4,38973069866801;0,00551101383482577;0,0265428421432425;0,0113416783109841;"IRAK1/TLR4/TLR7";3
"GO:1902106";"GO:1902106";"negative regulation of leukocyte differentiation";"2/19";"112/18888";0,0178571428571429;17,7518796992481;5,64228302203348;0,00557915117919851;0,0266534347832155;0,0113889342204819;"TLR4/FCGR2B";2
"GO:1905954";"GO:1905954";"positive regulation of lipid localization";"2/19";"112/18888";0,0178571428571429;17,7518796992481;5,64228302203348;0,00557915117919851;0,0266534347832155;0,0113889342204819;"APOE/C3";2
"GO:0030522";"GO:0030522";"intracellular receptor signaling pathway";"3/19";"369/18888";0,00813008130081301;8,0821566110398;4,35967175479006;0,00568025120548749;0,0270270017035292;0,0115485582658256;"IRAK1/TLR4/TLR7";3
"GO:0022037";"GO:0022037";"metencephalon development";"2/19";"115/18888";0,0173913043478261;17,2887871853547;5,55974250098099;0,00587287694963544;0,0278313044199591;0,0118922344488496;"FCGR2B/MECP2";2
"GO:0051347";"GO:0051347";"positive regulation of transferase activity";"3/19";"376/18888";0,00797872340425532;7,93169092945129;4,30814478364416;0,00598393984751783;0,0282441960802841;0,012068661839836;"APOE/IRAK1/TLR4";3
"GO:0009308";"GO:0009308";"amine metabolic process";"2/19";"118/18888";0,0169491525423729;16,8492417484389;5,4802605335235;0,00617358239234198;0,0289080445355696;0,0123523223305422;"MECP2/ITGAM";2
"GO:0010633";"GO:0010633";"negative regulation of epithelial cell migration";"2/19";"118/18888";0,0169491525423729;16,8492417484389;5,4802605335235;0,00617358239234198;0,0289080445355696;0,0123523223305422;"APOE/MECP2";2
"GO:0032609";"GO:0032609";"type II interferon production";"2/19";"119/18888";0,0168067226890756;16,7076514816453;5,4544129952182;0,00627536162791669;0,0290389283174184;0,0124082485852305;"TLR4/TLR7";2
"GO:0032649";"GO:0032649";"regulation of type II interferon production";"2/19";"119/18888";0,0168067226890756;16,7076514816453;5,4544129952182;0,00627536162791669;0,0290389283174184;0,0124082485852305;"TLR4/TLR7";2
"GO:1903707";"GO:1903707";"negative regulation of hemopoiesis";"2/19";"119/18888";0,0168067226890756;16,7076514816453;5,4544129952182;0,00627536162791669;0,0290389283174184;0,0124082485852305;"TLR4/FCGR2B";2
"GO:0002698";"GO:0002698";"negative regulation of immune effector process";"2/19";"121/18888";0,0165289256198347;16,4314919530231;5,40364765717025;0,0064812273211941;0,0298744071836291;0,0127652462452795;"FCGR2B/CR2";2
"GO:0002833";"GO:0002833";"positive regulation of response to biotic stimulus";"3/19";"390/18888";0,00769230769230769;7,64696356275304;4,20898194149169;0,00662035140733933;0,0303969442049043;0,0129885247762258;"IRAK1/TLR4/TLR7";3
"GO:0002286";"GO:0002286";"T cell activation involved in immune response";"2/19";"124/18888";0,0161290322580645;16,0339558573854;5,32973050337559;0,00679577170703088;0,0310814364895211;0,0132810063144341;"CD81/FCGR2B";2
"GO:0002824";"GO:0002824";"positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains";"2/19";"125/18888";0,016;15,9056842105263;5,30566263705072;0,00690214615223063;0,031325124844739;0,0133851336312489;"CD81/C3";2
"GO:1903305";"GO:1903305";"regulation of regulated secretory pathway";"2/19";"125/18888";0,016;15,9056842105263;5,30566263705072;0,00690214615223063;0,031325124844739;0,0133851336312489;"FCGR2B/ITGAM";2
"GO:0150063";"GO:0150063";"visual system development";"3/19";"397/18888";0,00755667506297229;7,51213045207477;4,16123262031203;0,00695324115844092;0,0314361094519551;0,0134325570271958;"C3/C1QA/ITGAM";3
"GO:0007613";"GO:0007613";"memory";"2/19";"126/18888";0,0158730158730159;15,7794486215539;5,28187096445947;0,00700928129926605;0,0315685188287555;0,0134891351641159;"APOE/MECP2";2
"GO:0046486";"GO:0046486";"glycerolipid metabolic process";"3/19";"400/18888";0,0075;7,45578947368421;4,14112402100627;0,00709893305358532;0,031811618556951;0,0135930109623368;"APOE/C3/MECP2";3
"GO:0071902";"GO:0071902";"positive regulation of protein serine/threonine kinase activity";"2/19";"127/18888";0,015748031496063;15,6552009946125;5,2583500792706;0,00711717567714837;0,031811618556951;0,0135930109623368;"IRAK1/TLR4";2
"GO:0002708";"GO:0002708";"positive regulation of lymphocyte mediated immunity";"2/19";"128/18888";0,015625;15,5328947368421;5,23509472278115;0,00722582781681007;0,0321459003012347;0,0137358485676106;"CD81/C3";2
"GO:0048880";"GO:0048880";"sensory system development";"3/19";"403/18888";0,00744416873449132;7,40028731879326;4,12122299700255;0,00724644871197326;0,0321459003012347;0,0137358485676106;"C3/C1QA/ITGAM";3
"GO:0002821";"GO:0002821";"positive regulation of adaptive immune response";"2/19";"131/18888";0,0152671755725191;15,1771795901969;5,16687134626238;0,00755631614457045;0,0333949552456671;0,0142695660683984;"CD81/C3";2
"GO:0038061";"GO:0038061";"non-canonical NF-kappaB signal transduction";"2/19";"135/18888";0,0148148148148148;14,727485380117;5,07932901964629;0,00800748712508606;0,0350136180076756;0,0149612159015848;"TLR4/TLR7";2
"GO:0045814";"GO:0045814";"negative regulation of gene expression, epigenetic";"2/19";"135/18888";0,0148148148148148;14,727485380117;5,07932901964629;0,00800748712508606;0,0350136180076756;0,0149612159015848;"DNMT3A/MECP2";2
"GO:0043254";"GO:0043254";"regulation of protein-containing complex assembly";"3/19";"418/18888";0,00717703349282297;7,1347267690758;4,02470234046407;0,00801159056107831;0,0350136180076756;0,0149612159015848;"APOE/TLR4/MECP2";3
"GO:0006639";"GO:0006639";"acylglycerol metabolic process";"2/19";"136/18888";0,0147058823529412;14,6191950464396;5,05802469116895;0,00812214870241225;0,0352357921648767;0,0150561502649205;"APOE/C3";2
"GO:0030168";"GO:0030168";"platelet activation";"2/19";"136/18888";0,0147058823529412;14,6191950464396;5,05802469116895;0,00812214870241225;0,0352357921648767;0,0150561502649205;"APOE/TLR4";2
"GO:0006638";"GO:0006638";"neutral lipid metabolic process";"2/19";"137/18888";0,0145985401459854;14,5124855935459;5,03694442376204;0,00823755490602274;0,035605548678047;0,0152141461345089;"APOE/C3";2
"GO:0010212";"GO:0010212";"response to ionizing radiation";"2/19";"138/18888";0,0144927536231884;14,4073226544622;5,01608418441094;0,00835370428594841;0,0358449856633423;0,015316456853471;"DNMT3A/MECP2";2
"GO:0046328";"GO:0046328";"regulation of JNK cascade";"2/19";"138/18888";0,0144927536231884;14,4073226544622;5,01608418441094;0,00835370428594841;0,0358449856633423;0,015316456853471;"TLR4/FCGR2B";2
"GO:0032388";"GO:0032388";"positive regulation of intracellular transport";"2/19";"140/18888";0,0142857142857143;14,2015037593985;4,97500816139688;0,00858822678435943;0,0366446763403612;0,0156581623256316;"CD81/MECP2";2
"GO:0003002";"GO:0003002";"regionalization";"3/19";"429/18888";0,00699300699300699;6,95178505704822;3,95690522522877;0,00860218249684751;0,0366446763403612;0,0156581623256316;"C3/C1QA/ITGAM";3
"GO:0051092";"GO:0051092";"positive regulation of NF-kappaB transcription factor activity";"2/19";"141/18888";0,0141843971631206;14,1007838745801;4,95478480563842;0,00870659701239102;0,0368236002674602;0,0157346159929647;"IRAK1/TLR4";2
"GO:0070828";"GO:0070828";"heterochromatin organization";"2/19";"141/18888";0,0141843971631206;14,1007838745801;4,95478480563842;0,00870659701239102;0,0368236002674602;0,0157346159929647;"DNMT3A/MECP2";2
"GO:0050671";"GO:0050671";"positive regulation of lymphocyte proliferation";"2/19";"143/18888";0,013986013986014;13,9035701140964;4,91494916978701;0,00894554821416802;0,0376990960454224;0,0161087127616033;"CD81/TLR4";2
"GO:0051223";"GO:0051223";"regulation of protein transport";"3/19";"440/18888";0,00681818181818182;6,77799043062201;3,89145811091148;0,00921802393166578;0,0387091396418705;0,0165403014169991;"CD81/APOE/TLR4";3
"GO:0032946";"GO:0032946";"positive regulation of mononuclear cell proliferation";"2/19";"146/18888";0,0136986301369863;13,6178803172314;4,85667132096745;0,009309480301977;0,0389545629657194;0,0166451700808025;"CD81/TLR4";2
"GO:2000377";"GO:2000377";"regulation of reactive oxygen species metabolic process";"2/19";"149/18888";0,0134228187919463;13,3436948074885;4,8000852708742;0,0096799843071035;0,0393972868265379;0,0168343446832397;"TLR4/ITGAM";2
"GO:0001915";"GO:0001915";"negative regulation of T cell mediated cytotoxicity";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"FCGR2B";1
"GO:0002291";"GO:0002291";"T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"CD81";1
"GO:0017038";"GO:0017038";"protein import";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"APOE";1
"GO:0045541";"GO:0045541";"negative regulation of cholesterol biosynthetic process";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"APOE";1
"GO:0050861";"GO:0050861";"positive regulation of B cell receptor signaling pathway";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"CD81";1
"GO:0070391";"GO:0070391";"response to lipoteichoic acid";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"TLR4";1
"GO:0070432";"GO:0070432";"regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"TLR4";1
"GO:0071223";"GO:0071223";"cellular response to lipoteichoic acid";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"TLR4";1
"GO:0097113";"GO:0097113";"AMPA glutamate receptor clustering";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"APOE";1
"GO:0097688";"GO:0097688";"glutamate receptor clustering";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"APOE";1
"GO:0106119";"GO:0106119";"negative regulation of sterol biosynthetic process";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"APOE";1
"GO:1902513";"GO:1902513";"regulation of organelle transport along microtubule";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"MECP2";1
"GO:1903799";"GO:1903799";"negative regulation of miRNA processing";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"MECP2";1
"GO:1903911";"GO:1903911";"positive regulation of receptor clustering";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"CD81";1
"GO:1905918";"GO:1905918";"regulation of CoA-transferase activity";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"APOE";1
"GO:2000563";"GO:2000563";"positive regulation of CD4-positive, alpha-beta T cell proliferation";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"CD81";1
"GO:2000822";"GO:2000822";"regulation of behavioral fear response";"1/19";"10/18888";0,1;99,4105263157895;9,8775084983995;0,0100162593626791;0,0393972868265379;0,0168343446832397;"APOE";1
"GO:1903531";"GO:1903531";"negative regulation of secretion by cell";"2/19";"152/18888";0,0131578947368421;13,0803324099723;4,74510785502675;0,0100570216411589;0,0394261977959053;0,0168466982553422;"APOE/FCGR2B";2
"GO:0015748";"GO:0015748";"organophosphate ester transport";"2/19";"154/18888";0,012987012987013;12,9104579630895;4,70931142921378;0,0103119905037823;0,0400396518231129;0,017108825355282;"APOE/SCARB2";2
"GO:0071456";"GO:0071456";"cellular response to hypoxia";"2/19";"154/18888";0,012987012987013;12,9104579630895;4,70931142921378;0,0103119905037823;0,0400396518231129;0,017108825355282;"IRAK1/DNMT3A";2
"GO:0008037";"GO:0008037";"cell recognition";"2/19";"155/18888";0,0129032258064516;12,8271646859083;4,691661548776;0,0104405538675558;0,0400396518231129;0,017108825355282;"CD81/C4B";2
"GO:0030183";"GO:0030183";"B cell differentiation";"2/19";"155/18888";0,0129032258064516;12,8271646859083;4,691661548776;0,0104405538675558;0,0400396518231129;0,017108825355282;"FCGR2B/CR2";2
"GO:0043535";"GO:0043535";"regulation of blood vessel endothelial cell migration";"2/19";"156/18888";0,0128205128205128;12,7449392712551;4,67417371191027;0,0105698346308729;0,0400396518231129;0,017108825355282;"APOE/MECP2";2
"GO:0030902";"GO:0030902";"hindbrain development";"2/19";"158/18888";0,0126582278481013;12,5836109260493;4,63967398411751;0,0108305427010165;0,0400396518231129;0,017108825355282;"FCGR2B/MECP2";2
"GO:0002604";"GO:0002604";"regulation of dendritic cell antigen processing and presentation";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"FCGR2B";1
"GO:0002887";"GO:0002887";"negative regulation of myeloid leukocyte mediated immunity";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"FCGR2B";1
"GO:0006678";"GO:0006678";"glucosylceramide metabolic process";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"SCARB2";1
"GO:0008063";"GO:0008063";"Toll signaling pathway";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"IRAK1";1
"GO:0031915";"GO:0031915";"positive regulation of synaptic plasticity";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"MECP2";1
"GO:0031987";"GO:0031987";"locomotion involved in locomotory behavior";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"MECP2";1
"GO:0034154";"GO:0034154";"toll-like receptor 7 signaling pathway";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"TLR7";1
"GO:0035666";"GO:0035666";"TRIF-dependent toll-like receptor signaling pathway";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"TLR4";1
"GO:0046477";"GO:0046477";"glycosylceramide catabolic process";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"SCARB2";1
"GO:0090206";"GO:0090206";"negative regulation of cholesterol metabolic process";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"APOE";1
"GO:0099519";"GO:0099519";"dense core granule cytoskeletal transport";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"MECP2";1
"GO:1901950";"GO:1901950";"dense core granule transport";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"MECP2";1
"GO:1903365";"GO:1903365";"regulation of fear response";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"APOE";1
"GO:1904464";"GO:1904464";"regulation of matrix metallopeptidase secretion";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"TLR4";1
"GO:1990773";"GO:1990773";"matrix metallopeptidase secretion";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"TLR4";1
"GO:2000343";"GO:2000343";"positive regulation of chemokine (C-X-C motif) ligand 2 production";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"TLR4";1
"GO:2000644";"GO:2000644";"regulation of receptor catabolic process";"1/19";"11/18888";0,0909090909090909;90,3732057416268;9,40851407742253;0,0110126409217487;0,0400396518231129;0,017108825355282;"APOE";1
"GO:0045859";"GO:0045859";"regulation of protein kinase activity";"3/19";"470/18888";0,00638297872340425;6,34535274356103;3,72381342179775;0,0110278702055184;0,0400396518231129;0,017108825355282;"APOE/IRAK1/TLR4";3
"GO:0010976";"GO:0010976";"positive regulation of neuron projection development";"2/19";"161/18888";0,0124223602484472;12,3491337038248;4,58907751619251;0,0112269500070829;0,0405131529307579;0,017311150984686;"APOE/SCARB2";2
"GO:0036294";"GO:0036294";"cellular response to decreased oxygen levels";"2/19";"161/18888";0,0124223602484472;12,3491337038248;4,58907751619251;0,0112269500070829;0,0405131529307579;0,017311150984686;"IRAK1/DNMT3A";2
"GO:0007389";"GO:0007389";"pattern specification process";"3/19";"474/18888";0,00632911392405063;6,29180546302465;3,70256609688237;0,0112837594669171;0,0405940127163479;0,0173457021330336;"C3/C1QA/ITGAM";3
"GO:0070665";"GO:0070665";"positive regulation of leukocyte proliferation";"2/19";"164/18888";0,0121951219512195;12,1232349165597;4,53980883354643;0,0116297378016273;0,0417115215985417;0,0178232103886722;"CD81/TLR4";2
"GO:1903829";"GO:1903829";"positive regulation of protein localization";"3/19";"483/18888";0,0062111801242236;6,17456685191239;3,65564070926587;0,0118721802443521;0,0417980100884039;0,0178601666657854;"CD81/TLR4/ITGAM";3
"GO:0002638";"GO:0002638";"negative regulation of immunoglobulin production";"1/19";"12/18888";0,0833333333333333;82,8421052631579;8,99904201555825;0,0120080723898042;0,0417980100884039;0,0178601666657854;"FCGR2B";1
"GO:0002674";"GO:0002674";"negative regulation of acute inflammatory response";"1/19";"12/18888";0,0833333333333333;82,8421052631579;8,99904201555825;0,0120080723898042;0,0417980100884039;0,0178601666657854;"FCGR2B";1
"GO:0010572";"GO:0010572";"positive regulation of platelet activation";"1/19";"12/18888";0,0833333333333333;82,8421052631579;8,99904201555825;0,0120080723898042;0,0417980100884039;0,0178601666657854;"TLR4";1
"GO:0014072";"GO:0014072";"response to isoquinoline alkaloid";"1/19";"12/18888";0,0833333333333333;82,8421052631579;8,99904201555825;0,0120080723898042;0,0417980100884039;0,0178601666657854;"MECP2";1
"GO:0034370";"GO:0034370";"triglyceride-rich lipoprotein particle remodeling";"1/19";"12/18888";0,0833333333333333;82,8421052631579;8,99904201555825;0,0120080723898042;0,0417980100884039;0,0178601666657854;"APOE";1
"GO:0034372";"GO:0034372";"very-low-density lipoprotein particle remodeling";"1/19";"12/18888";0,0833333333333333;82,8421052631579;8,99904201555825;0,0120080723898042;0,0417980100884039;0,0178601666657854;"APOE";1
"GO:0043312";"GO:0043312";"neutrophil degranulation";"1/19";"12/18888";0,0833333333333333;82,8421052631579;8,99904201555825;0,0120080723898042;0,0417980100884039;0,0178601666657854;"ITGAM";1
"GO:0048755";"GO:0048755";"branching morphogenesis of a nerve";"1/19";"12/18888";0,0833333333333333;82,8421052631579;8,99904201555825;0,0120080723898042;0,0417980100884039;0,0178601666657854;"MECP2";1
"GO:1905671";"GO:1905671";"regulation of lysosome organization";"1/19";"12/18888";0,0833333333333333;82,8421052631579;8,99904201555825;0,0120080723898042;0,0417980100884039;0,0178601666657854;"SCARB2";1
"GO:0043409";"GO:0043409";"negative regulation of MAPK cascade";"2/19";"170/18888";0,0117647058823529;11,6953560371517;4,44502117280547;0,0124543036683698;0,0428575822753185;0,0183129187420852;"APOE/TLR4";2
"GO:0051048";"GO:0051048";"negative regulation of secretion";"2/19";"173/18888";0,0115606936416185;11,492546394889;4,39939424586345;0,0128760065195857;0,0428575822753185;0,0183129187420852;"APOE/FCGR2B";2
"GO:0002087";"GO:0002087";"regulation of respiratory gaseous exchange by nervous system process";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"MECP2";1
"GO:0014004";"GO:0014004";"microglia differentiation";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"TLR4";1
"GO:0021794";"GO:0021794";"thalamus development";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"MECP2";1
"GO:0034380";"GO:0034380";"high-density lipoprotein particle assembly";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"APOE";1
"GO:0035745";"GO:0035745";"T-helper 2 cell cytokine production";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"CD81";1
"GO:0035865";"GO:0035865";"cellular response to potassium ion";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"MECP2";1
"GO:0036006";"GO:0036006";"cellular response to macrophage colony-stimulating factor stimulus";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"TLR4";1
"GO:0043301";"GO:0043301";"negative regulation of leukocyte degranulation";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"FCGR2B";1
"GO:0045916";"GO:0045916";"negative regulation of complement activation";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"CR2";1
"GO:0048521";"GO:0048521";"negative regulation of behavior";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"MECP2";1
"GO:0060100";"GO:0060100";"positive regulation of phagocytosis, engulfment";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"C3";1
"GO:0060965";"GO:0060965";"negative regulation of miRNA-mediated gene silencing";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"MECP2";1
"GO:1904350";"GO:1904350";"regulation of protein catabolic process in the vacuole";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"CD81";1
"GO:1905155";"GO:1905155";"positive regulation of membrane invagination";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"C3";1
"GO:1905907";"GO:1905907";"negative regulation of amyloid fibril formation";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"APOE";1
"GO:2000551";"GO:2000551";"regulation of T-helper 2 cell cytokine production";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"CD81";1
"GO:2001198";"GO:2001198";"regulation of dendritic cell differentiation";"1/19";"13/18888";0,0769230769230769;76,4696356275304;8,63742516378836;0,0130025546225119;0,0428575822753185;0,0183129187420852;"FCGR2B";1
"GO:1902905";"GO:1902905";"positive regulation of supramolecular fiber organization";"2/19";"175/18888";0,0114285714285714;11,3612030075188;4,36959662024505;0,0131606051919326;0,0432576995166587;0,0184838876614447;"APOE/MECP2";2
"GO:0032635";"GO:0032635";"interleukin-6 production";"2/19";"176/18888";0,0113636363636364;11,2966507177034;4,35487866022748;0,0133039394163474;0,0434865609731024;0,0185816794880607;"TLR4/TLR7";2
"GO:0032675";"GO:0032675";"regulation of interleukin-6 production";"2/19";"176/18888";0,0113636363636364;11,2966507177034;4,35487866022748;0,0133039394163474;0,0434865609731024;0,0185816794880607;"TLR4/TLR7";2
"GO:0050806";"GO:0050806";"positive regulation of synaptic transmission";"2/19";"177/18888";0,0112994350282486;11,2328278322926;4,34027901812427;0,0134479617290807;0,0435950407700969;0,0186280325859736;"APOE/MECP2";2
"GO:0071453";"GO:0071453";"cellular response to oxygen levels";"2/19";"177/18888";0,0112994350282486;11,2328278322926;4,34027901812427;0,0134479617290807;0,0435950407700969;0,0186280325859736;"IRAK1/DNMT3A";2
"GO:1990138";"GO:1990138";"neuron projection extension";"2/19";"177/18888";0,0112994350282486;11,2328278322926;4,34027901812427;0,0134479617290807;0,0435950407700969;0,0186280325859736;"APOE/MECP2";2
"GO:1905475";"GO:1905475";"regulation of protein localization to membrane";"2/19";"180/18888";0,0111111111111111;11,0456140350877;4,29717369296039;0,0138841434502182;0,0439163585316575;0,0187653307195932;"CD81/ITGAM";2
"GO:0001976";"GO:0001976";"nervous system process involved in regulation of systemic arterial blood pressure";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"MECP2";1
"GO:0033700";"GO:0033700";"phospholipid efflux";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"APOE";1
"GO:0045348";"GO:0045348";"positive regulation of MHC class II biosynthetic process";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"TLR4";1
"GO:0060149";"GO:0060149";"negative regulation of post-transcriptional gene silencing";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"MECP2";1
"GO:0060967";"GO:0060967";"negative regulation of gene silencing by regulatory ncRNA";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"MECP2";1
"GO:0061000";"GO:0061000";"negative regulation of dendritic spine development";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"MECP2";1
"GO:0071361";"GO:0071361";"cellular response to ethanol";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"DNMT3A";1
"GO:0140052";"GO:0140052";"cellular response to oxidised low-density lipoprotein particle stimulus";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"TLR4";1
"GO:1900272";"GO:1900272";"negative regulation of long-term synaptic potentiation";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"APOE";1
"GO:1900369";"GO:1900369";"negative regulation of post-transcriptional gene silencing by regulatory ncRNA";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"MECP2";1
"GO:2001140";"GO:2001140";"positive regulation of phospholipid transport";"1/19";"14/18888";0,0714285714285714;71,0075187969925;8,31496789232277;0,0139960884748124;0,0439163585316575;0,0187653307195932;"APOE";1
"GO:0043414";"GO:0043414";"macromolecule methylation";"2/19";"181/18888";0,0110497237569061;10,9845885431812;4,28303117344974;0,0140309043783346;0,0439163585316575;0,0187653307195932;"DNMT3A/MECP2";2
"GO:0043534";"GO:0043534";"blood vessel endothelial cell migration";"2/19";"183/18888";0,0109289617486339;10,8645383951682;4,25507583432294;0,0143264685533785;0,0447228383412345;0,01910993716811;"APOE/MECP2";2
"GO:1905952";"GO:1905952";"regulation of lipid localization";"2/19";"186/18888";0,010752688172043;10,6893039049236;4,2139450872995;0,0147749001420529;0,0455841140852766;0,0194779577581155;"APOE/C3";2
"GO:0046890";"GO:0046890";"regulation of lipid biosynthetic process";"2/19";"187/18888";0,0106951871657754;10,6321418519561;4,20044310285026;0,014925727978967;0,0455841140852766;0,0194779577581155;"APOE/C3";2
"GO:0033189";"GO:0033189";"response to vitamin A";"1/19";"15/18888";0,0666666666666667;66,2736842105263;8,02503867419389;0,0149886748009215;0,0455841140852766;0,0194779577581155;"DNMT3A";1
"GO:0045472";"GO:0045472";"response to ether";"1/19";"15/18888";0,0666666666666667;66,2736842105263;8,02503867419389;0,0149886748009215;0,0455841140852766;0,0194779577581155;"ITGAM";1
"GO:0060099";"GO:0060099";"regulation of phagocytosis, engulfment";"1/19";"15/18888";0,0666666666666667;66,2736842105263;8,02503867419389;0,0149886748009215;0,0455841140852766;0,0194779577581155;"C3";1
"GO:0070424";"GO:0070424";"regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway";"1/19";"15/18888";0,0666666666666667;66,2736842105263;8,02503867419389;0,0149886748009215;0,0455841140852766;0,0194779577581155;"TLR4";1
"GO:0070863";"GO:0070863";"positive regulation of protein exit from endoplasmic reticulum";"1/19";"15/18888";0,0666666666666667;66,2736842105263;8,02503867419389;0,0149886748009215;0,0455841140852766;0,0194779577581155;"CD81";1
"GO:0090205";"GO:0090205";"positive regulation of cholesterol metabolic process";"1/19";"15/18888";0,0666666666666667;66,2736842105263;8,02503867419389;0,0149886748009215;0,0455841140852766;0,0194779577581155;"APOE";1
"GO:1905153";"GO:1905153";"regulation of membrane invagination";"1/19";"15/18888";0,0666666666666667;66,2736842105263;8,02503867419389;0,0149886748009215;0,0455841140852766;0,0194779577581155;"C3";1
"GO:2001138";"GO:2001138";"regulation of phospholipid transport";"1/19";"15/18888";0,0666666666666667;66,2736842105263;8,02503867419389;0,0149886748009215;0,0455841140852766;0,0194779577581155;"APOE";1
"GO:0017157";"GO:0017157";"regulation of exocytosis";"2/19";"188/18888";0,0106382978723404;10,5755879059351;4,18704296417204;0,0150772288722021;0,045735552877117;0,0195426671080634;"FCGR2B/ITGAM";2
"GO:0060759";"GO:0060759";"regulation of response to cytokine stimulus";"2/19";"189/18888";0,0105820105820106;10,5196324143693;4,17374333734265;0,0152294014660432;0,0460787018716178;0,0196892936632515;"IRAK1/TLR4";2
"GO:0001771";"GO:0001771";"immunological synapse formation";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"CD81";1
"GO:0002468";"GO:0002468";"dendritic cell antigen processing and presentation";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"FCGR2B";1
"GO:0002756";"GO:0002756";"MyD88-independent toll-like receptor signaling pathway";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"TLR4";1
"GO:0032048";"GO:0032048";"cardiolipin metabolic process";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"MECP2";1
"GO:0034374";"GO:0034374";"low-density lipoprotein particle remodeling";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"APOE";1
"GO:0035641";"GO:0035641";"locomotory exploration behavior";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"APOE";1
"GO:0044065";"GO:0044065";"regulation of respiratory system process";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"MECP2";1
"GO:0048712";"GO:0048712";"negative regulation of astrocyte differentiation";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"MECP2";1
"GO:0051044";"GO:0051044";"positive regulation of membrane protein ectodomain proteolysis";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"APOE";1
"GO:0051770";"GO:0051770";"positive regulation of nitric-oxide synthase biosynthetic process";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"TLR4";1
"GO:1903798";"GO:1903798";"regulation of miRNA processing";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"MECP2";1
"GO:1903909";"GO:1903909";"regulation of receptor clustering";"1/19";"16/18888";0,0625;62,1315789473684;7,7624799060018;0,0159803144543302;0,0468494920385638;0,0200186500325353;"CD81";1
"GO:0050777";"GO:0050777";"negative regulation of immune response";"2/19";"194/18888";0,0103092783505155;10,2485078676072;4,10870787568212;0,0160002926199502;0,0468494920385638;0,0200186500325353;"FCGR2B/CR2";2
"GO:0099173";"GO:0099173";"postsynapse organization";"2/19";"196/18888";0,0102040816326531;10,1439312567132;4,08335323157438;0,0163133037365919;0,0476477683395506;0,020359751145981;"APOE/FCGR2B";2
"GO:0031334";"GO:0031334";"positive regulation of protein-containing complex assembly";"2/19";"197/18888";0,0101522842639594;10,0924392198771;4,07081249941267;0,0164708013447037;0,0477942476840381;0,0204223413386746;"TLR4/MECP2";2
"GO:0002730";"GO:0002730";"regulation of dendritic cell cytokine production";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"TLR4";1
"GO:0008228";"GO:0008228";"opsonization";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"C4B";1
"GO:0030889";"GO:0030889";"negative regulation of B cell proliferation";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"FCGR2B";1
"GO:0032488";"GO:0032488";"Cdc42 protein signal transduction";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"APOE";1
"GO:0034134";"GO:0034134";"toll-like receptor 2 signaling pathway";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"IRAK1";1
"GO:0034375";"GO:0034375";"high-density lipoprotein particle remodeling";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"APOE";1
"GO:0036005";"GO:0036005";"response to macrophage colony-stimulating factor";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"TLR4";1
"GO:0043031";"GO:0043031";"negative regulation of macrophage activation";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"FCGR2B";1
"GO:0051000";"GO:0051000";"positive regulation of nitric-oxide synthase activity";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"APOE";1
"GO:0055089";"GO:0055089";"fatty acid homeostasis";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"APOE";1
"GO:0070920";"GO:0070920";"regulation of regulatory ncRNA processing";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"MECP2";1
"GO:0072578";"GO:0072578";"neurotransmitter-gated ion channel clustering";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"APOE";1
"GO:0090209";"GO:0090209";"negative regulation of triglyceride metabolic process";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"APOE";1
"GO:1905906";"GO:1905906";"regulation of amyloid fibril formation";"1/19";"17/18888";0,0588235294117647;58,4767801857585;7,52321170254048;0,0169710082878067;0,0477942476840381;0,0204223413386746;"APOE";1
"GO:0050728";"GO:0050728";"negative regulation of inflammatory response";"2/19";"201/18888";0,00995024875621891;9,89159465828751;4,02153396098189;0,0171073742054375;0,04806357514861;0,02053742417144;"APOE/FCGR2B";2
"GO:0007626";"GO:0007626";"locomotory behavior";"2/19";"202/18888";0,0099009900990099;9,84262636789995;4,00943000180423;0,0172681563518232;0,0484000581832575;0,020681202381606;"APOE/MECP2";2
"GO:0045732";"GO:0045732";"positive regulation of protein catabolic process";"2/19";"205/18888";0,00975609756097561;9,69858793324775;3,97361905953625;0,0177544149269065;0,0484981543272462;0,0207231185751569;"CD81/APOE";2
"GO:0002371";"GO:0002371";"dendritic cell cytokine production";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"TLR4";1
"GO:0002830";"GO:0002830";"positive regulation of type 2 immune response";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"CD81";1
"GO:0010544";"GO:0010544";"negative regulation of platelet activation";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"APOE";1
"GO:0032930";"GO:0032930";"positive regulation of superoxide anion generation";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"ITGAM";1
"GO:0034162";"GO:0034162";"toll-like receptor 9 signaling pathway";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"IRAK1";1
"GO:0034384";"GO:0034384";"high-density lipoprotein particle clearance";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"APOE";1
"GO:0035864";"GO:0035864";"response to potassium ion";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"MECP2";1
"GO:0042053";"GO:0042053";"regulation of dopamine metabolic process";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"ITGAM";1
"GO:0042069";"GO:0042069";"regulation of catecholamine metabolic process";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"ITGAM";1
"GO:0043117";"GO:0043117";"positive regulation of vascular permeability";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"APOE";1
"GO:0044030";"GO:0044030";"regulation of DNA methylation";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"MECP2";1
"GO:0045346";"GO:0045346";"regulation of MHC class II biosynthetic process";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"TLR4";1
"GO:0050862";"GO:0050862";"positive regulation of T cell receptor signaling pathway";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"CD81";1
"GO:0090713";"GO:0090713";"immunological memory process";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"CD81";1
"GO:0099638";"GO:0099638";"endosome to plasma membrane protein transport";"1/19";"18/18888";0,0555555555555556;55,2280701754386;7,30395855582629;0,0179607571533954;0,0484981543272462;0,0207231185751569;"SCARB2";1
"GO:0043123";"GO:0043123";"positive regulation of canonical NF-kappaB signal transduction";"2/19";"208/18888";0,00961538461538462;9,5587044534413;3,93853863150822;0,0182465138531075;0,0490452991951408;0,0209569119665232;"IRAK1/TLR4";2
"GO:0050851";"GO:0050851";"antigen receptor-mediated signaling pathway";"2/19";"208/18888";0,00961538461538462;9,5587044534413;3,93853863150822;0,0182465138531075;0,0490452991951408;0,0209569119665232;"CD81/FCGR2B";2
"GO:0002283";"GO:0002283";"neutrophil activation involved in immune response";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"ITGAM";1
"GO:0010968";"GO:0010968";"regulation of microtubule nucleation";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"MECP2";1
"GO:0031053";"GO:0031053";"primary miRNA processing";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"MECP2";1
"GO:0035743";"GO:0035743";"CD4-positive, alpha-beta T cell cytokine production";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"CD81";1
"GO:0043045";"GO:0043045";"post-fertilization epigenetic regulation of gene expression";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"DNMT3A";1
"GO:0045342";"GO:0045342";"MHC class II biosynthetic process";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"TLR4";1
"GO:0050884";"GO:0050884";"neuromuscular process controlling posture";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"MECP2";1
"GO:0070431";"GO:0070431";"nucleotide-binding oligomerization domain containing 2 signaling pathway";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"TLR4";1
"GO:0098543";"GO:0098543";"detection of other organism";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"TLR4";1
"GO:1902931";"GO:1902931";"negative regulation of alcohol biosynthetic process";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"APOE";1
"GO:1903428";"GO:1903428";"positive regulation of reactive oxygen species biosynthetic process";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"TLR4";1
"GO:1905038";"GO:1905038";"regulation of membrane lipid metabolic process";"1/19";"19/18888";0,0526315789473684;52,3213296398892;7,1020562262089;0,0189495619024198;0,0495797850218523;0,0211852961868575;"SCARB2";1
